Outcomes of Pasi and Pasi Components in Two Phase 3 Trials of Deucravacitinib in Patients with Moderate to Severe Plaque Psoriasis
AuthID
P-019-040
P-019-040
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service